Acta Biochimica et Biophysica Sinica · 2016 · 65 citations · 27 references
MedicineMolecular BiologyOncologyCarcinogenesisMolecular OncologyOncogenesCancer Cell SignalingCancer ProgressionMicrorna BiologyOncogenic Signaling PathwaysPancreatic CancerPancreatic DiseasesCanonical Beta-catenin SignalingMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna-mediated OncogenesisOncogenic TransformationTumor Cell Proliferation
Pancreatic cancer is an aggressive malignancy. The median survival rate remains low, indicating that the identification of novel biomarkers and therapeutic targets is critical. Here, we examined the role of microRNA-182 (miR-182) in pancreatic cancer development. Analysis of human pancreatic cancer specimens and cell lines showed that miR-182 is overexpressed in pancreatic cancer and promotes tumor proliferation and invasion. β-TrCP2 was confirmed as a direct target of miR-182. Silencing of β-TrCP2 increased the levels of β-catenin, which is similar to miR-182 overexpression. Ectopic expression of β-TrCP2 inhibited the miR-182-induced activation of β-catenin signaling. The oncogenic effect of miR-182 and its reversal by β-TrCP2 were confirmed in vivo This study suggests that β-TrCP and miR-182 may be possible biomarkers and targets for early detection and treatment of pancreatic cancer.
27
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Chunming Liu, Yiming Li, Mikhail A. Semenov et al. · Cell · 2002 · 2.1K citations · Full text
Expression profiling identifies microRNA signature in pancreatic cancer
Eun Joo Lee, Yuriy Gusev, Jinmai Jiang et al. · International Journal of Cancer · 2006 · 906 citations · Full text
Medicine, Cancer Biology, Oncology +17
Miguel F. Segura, Douglas Hanniford, Sílvia Menéndez et al. · Proceedings of the National Academy of Sciences · 2009 · 541 citations · Full text